As the FDA inches toward approving food products from cloned animals, the EU stays mute, setting up another potential trade conflict. After many years of…
The discovery of traces of unapproved genetically modified rice in United States exports has once again put the spotlight on biotech companies’ failure to fully…
In often delayed, still secret, but not unexpected preliminary findings, a three-person expert panel at the World Trade Organization (WTO) in Geneva, on February 7…
In what could be a milestone for veterinary as well as human vaccine research, the US Department of Agriculture (USDA) on January 31, 2006, announced…
Most maize and soy products sold in South African food stores contain detectable amounts of genetically modified organisms (GMOs), including products that are labeled ‘non-GMO,’…
US President George W. Bush on January 31, in his State of the Union address to Congress, created a buzz around biofuels by announcing a…
The World Trade Organization (WTO) has proposed to make permanent a ‘temporary waiver’ under its agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS).…
A lobbying group for French biotech companies has reacted angrily to the surprising acquittal of 49 activists who had demolished field trials of genetically modified…
In an attempt to promote drug development by young and innovative companies in Europe, the London-based European Medicines Agency (EMEA) unveiled a new storefront targeted…
On November 16, the European Commission proposed closing a market authorization hole in Europe by regulating tissue-engineering products as ‘advanced therapies’ rather than medical devices.…